Adding value to your assets, our aim

Our aim

  • Finding a use for existing advanced small molecules in the therapeutic treatment of atopic dermatitis, psoriasis, actinic keratosis, acne, and related dermatological diseases.
    • We are looking for compounds addressing a specific target or pathway in a selective manner with a scientific rationale that supports their use on one or more indications of interest
    • More specifically, Research compounds that have shown a good potency and an acceptable pharmacokinetic profile or Development compounds that have shown a good human safety profile

Our partners

  • Universities
  • Research Centers
  • Start-ups
  • Biotechs
  • Pharmaceutical companies

world-wide with an interest in pharmaceutical R&D

You benefits

  • Biological profiling of your small molecule on key dermatological assays in vitro and in vivo
  • Opportunity for an eventual long-term collaboration with us beyond the initial project
  • Your intellectual property rights are protected
    • No need to disclose the chemical structure of your compound
    • All data and results generated will be treated as strictly confidential and will only be used to decide about future collaboration options
    • You will be the owner of the results obtained
    • We expect you not to patent, register, or communicate to any third party the results we generated whilst we are collaborating
  • A specific contact person to help you with any questions will be available at any tim

Collaboration process

  • Submit your proposal
    • As an initial step, you should create an account in AlmirallShare Innovation platform, a secure tool to keep and manage your proposals
    • You can submit your proposal at any time
    • All the initial information provided under the proposal should be non-confidential. Please do not reveal the chemical structure of your compound, even if it is published
    • Please include an outline of your proposal (max. 300 words) and a detailed description of your advanced compound properties, including at least biological data such as target and affinities (IC50, Ki…etc), and available ADME data
  • Proposal evaluation
    • A team of Almirall scientific experts will evaluate your proposal
    • The evaluation process will have a duration of 4-6 weeks after proposal submission
  • Proposal selection
    • After the evaluation period, you will receive Almirall’s decision regarding the progression of your proposal
  • Collaboration starts
    • If your proposal has been selected, we will help you to draft a Material Transfer Agreement (MTA)
    • Compounds will be tested in a pre-agreed panel of relevant cellular assays and in vivo disease models within a period of 4-6 months, starting upon MTA signature. This panel could be complemented with other assays, such as physicochemical properties and pharmacokinetic studies

For Universities, Research Centers, Start-ups, Biotechs and Pharma companies

Submit your proposal at any time

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our policy of cookies, click on the link for more information.

Aviso de cookies